Apical hypertrophic cardiomyopathy is a rare condition with a generally favorable prognosis that is best diagnosed using echocardiography and CMR, and can be managed with medical therapy or surgical apical myectomy in refractory cases.
Supports conservative AHCM management given low mortality; leaves open prospective risk-stratification trials.
Apical hypertrophic cardiomyopathy (AHCM) is a rare form of hypertrophic cardiomyopathy, occasionally resulting in severe complications. The paper covers the etiology and pathogenesis of AHCM, different imaging methods and characteristic appearance of the disease in each of them. Echocardiography and cardiovascular magnetic resonance imaging (CMR) are known to be the most valuable imaging methods. Moreover, this review presents medical and surgical treatment, as well as the clinical course and prognosis. Despite possible morbid events the overall cardiovascular mortality rate of AHCM patients is low, and the prognosis is relatively optimistic.
No takes yet. Share an insight, caveat, or question.
Paluszkiewicz et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: